Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990)
167.00
0.00 (0.00%)
At close: Sep 9, 2024
Sichuan Kelun-Biotech Biopharmaceutical Revenue
Sichuan Kelun-Biotech Biopharmaceutical had revenue of 1.38B CNY in the half year ending June 30, 2024, with 300.82% growth. This brings the company's revenue in the last twelve months to 1.88B, up 24.71% year-over-year. In the year 2023, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 1.54B with 91.62% growth.
Revenue (ttm)
1.88B CNY
Revenue Growth
+24.71%
P/S Ratio
18.01
Revenue / Employee
1.27M CNY
Employees
1,477
Market Cap
37.21B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.54B | 736.56M | 91.62% |
Dec 31, 2022 | 803.93M | 771.61M | 2,387.26% |
Dec 31, 2021 | 32.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition